Clinical Trial Update: Contrast-Enhanced Ultrasound in Human Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating contrast-enhanced ultrasound for Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: University of Michigan | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: WITHDRAWN